Taken together, we have shown that candesartan elicits its anti-cancer effects by suppressing CRC cell growth and migration, impairing oxidant/antioxidant balance, and enhancing tumor necrosis in CRC cells and tumors, suggesting the therapeutic potential of targeting renin-angiotensin system in colon cancer treatment. Here, REN is linked to malignant colon neoplasm.